The impact of the 21-gene recurrence score assay on decision making about adjuvant chemotherapy in early-stage estrogen-receptor-positive breast cancer in an oncology practice with a unified treatment policy.
D. Geffen, S. Abu-Ghanem, N. Sion-Vardy, R. Braunstein +5 more

